Norbrook Laboratories (Feline Hyperthyroidism Drug) Overview
- Year Founded
-
2016
- Status
-
Acquired/Merged
- Latest Deal Type
-
Asset Purch.
- Financing Rounds
-
1
Norbrook Laboratories (Feline Hyperthyroidism Drug) General Information
Description
A Feline Hyperthyroidism Drug.
Contact Information
Corporate Office
- Newry
- Northern Ireland, United Kingdom
Corporate Office
- Newry
- Northern Ireland, United Kingdom
Norbrook Laboratories (Feline Hyperthyroidism Drug) Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Norbrook Laboratories (Feline Hyperthyroidism Drug) Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Norbrook Laboratories (Feline Hyperthyroidism Drug) FAQs
-
When was Norbrook Laboratories (Feline Hyperthyroidism Drug) founded?
Norbrook Laboratories (Feline Hyperthyroidism Drug) was founded in 2016.
-
Where is Norbrook Laboratories (Feline Hyperthyroidism Drug) headquartered?
Norbrook Laboratories (Feline Hyperthyroidism Drug) is headquartered in Newry, United Kingdom.
-
What industry is Norbrook Laboratories (Feline Hyperthyroidism Drug) in?
Norbrook Laboratories (Feline Hyperthyroidism Drug)’s primary industry is Buildings and Property.
-
Is Norbrook Laboratories (Feline Hyperthyroidism Drug) a private or public company?
Norbrook Laboratories (Feline Hyperthyroidism Drug) is a Private company.
-
What is the current valuation of Norbrook Laboratories (Feline Hyperthyroidism Drug)?
The current valuation of Norbrook Laboratories (Feline Hyperthyroidism Drug) is .
-
What is Norbrook Laboratories (Feline Hyperthyroidism Drug)’s current revenue?
The current revenue for Norbrook Laboratories (Feline Hyperthyroidism Drug) is .
-
Who are Norbrook Laboratories (Feline Hyperthyroidism Drug)’s investors?
Norbrook Laboratories has invested in Norbrook Laboratories (Feline Hyperthyroidism Drug).
-
When was Norbrook Laboratories (Feline Hyperthyroidism Drug) acquired?
Norbrook Laboratories (Feline Hyperthyroidism Drug) was acquired on 16-Dec-2025.
-
Who acquired Norbrook Laboratories (Feline Hyperthyroidism Drug)?
Norbrook Laboratories (Feline Hyperthyroidism Drug) was acquired by Virbac.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process